Metraipolis › archive › dc_7e88daa31a88

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps — Europe PMC PMID:42459698

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42459698
DOI
10.3389/fimmu.2026.1856088
License (as archived)
solo-consultazione
Archived
2026-10-08T00:47:29.865Z
SHA-256 of the archived text
6cd2ff5a83a7b8a8e3788070da8f96ee28be35ce90d1f2674ecbe6a37a7cab38
Stable URL of this page
https://metraipolis.com/documento/dc_7e88daa31a88

How to cite

Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps — Europe PMC PMID:42459698 — Europe PMC (en), https://europepmc.org/article/MED/42459698 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e88daa31a88 (Metraipolis archive dc_7e88daa31a88, sha256 6cd2ff5a83a7b8a8e3788070da8f96ee28be35ce90d1f2674ecbe6a37a7cab38)
BibTeX
@misc{dc7e88daa31a88,
  title = {Immuno-phage synergy driven by fitness costs: turning bacterial phage resistance into therapeutic gain through evolutionary traps — Europe PMC PMID:42459698},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42459698},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e88daa31a88; sha256 6cd2ff5a83a7b8a8e3788070da8f96ee28be35ce90d1f2674ecbe6a37a7cab38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42459698. Agents can read the archived copy with the MCP tool read_document.